6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T18813 | Thalidomide-PEG2-C2-NH2 | Thalidomide-NH-PEG2-C2-NH2 | Others |
Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1]. | |||
T18819 | Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride | Others , Ligand for E3 Ligase | |
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride incorporates an E3 ligase ligand and a linker. Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride can be used as an immunomodulator for the treatment of cancer. | |||
T17918 | Thalidomide-O-amido-PEG2-C2-NH2 TFA | E3 Ligase Ligand-Linker Conjugates 24 TFA,Cereblon Ligand-Linker Conjugates 10 TFA | Others , E3 Ligase Ligand-Linker Conjugate |
Thalidomide-O-amido-PEG2-C2-NH2 TFA (E3 Ligase Ligand-Linker Conjugates 24 TFA) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG2-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand a... | |||
T39375 | Thalidomide-O-amido-PEG2-C2-NH2 | Cereblon Ligand-Linker Conjugates 10,E3LigaseLigand-LinkerConjugates24,Thalidomide-O-amido-PEG2-C2-NH2 | |
Thalidomide-O-amido-PEG2-C2-NH2, which combines an E3 ligase ligand with a linker, serves as an immunomodulator for cancer treatment. | |||
T18812 | Thalidomide-PEG2-C2-NH2 TFA | Thalidomide-NH-PEG2-C2-NH2 TFA | Others |
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker for use in PROTAC technology[1]. | |||
T18811 | Thalidomide-PEG2-C2-NH2 hydrochloride | Thalidomide-NH-PEG2-C2-NH2 hydrochloride | Others |
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1]. |